CLNN — Clene Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1822791 ·
Last close
$6.57
Market Cap
$83.95M
52W High
$8.67
52W Low
$4.45
ADV30
929,109
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 15,000 | 15,000 | -1,692,000 | -8,091,000 | 21,665,000 | 5,939,000 | 40,471,000 |
| Dec 2025 | 77,000 | 54,000 | -7,244,000 | -9,226,000 | 18,131,000 | 5,189,000 | 35,723,000 |
| Sep 2025 | 15,000 | 15,000 | -5,373,000 | -8,777,000 | 22,311,000 | 7,925,000 | 34,668,000 |
| Jun 2025 | 27,000 | 27,000 | -5,628,000 | -7,419,000 | 22,125,000 | 7,285,000 | 30,675,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,546,000
Investing CF
$-39,000
Financing CF
$11,518,000
CapEx
$-30,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.94
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-308,296,000
Inventory
$37,000
Receivables
$590,000
ST Investments
$0
EBIT TTM
$-23,491,000
Pretax Income TTM
$-26,173,000
Interest Exp TTM
$2,682,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$134,000
EBITDA
$-19,622,000
Free Cash Flow
$-11,576,125
Enterprise Value
$101,723,656
Total Cash
$5,939,000
Total Debt
$22,048,000
Shares Out
12,778,307
Trailing EPS
$-3.27
Book Value
$-1.60
ROE
—
ROA
-56.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 200,000 | -21,816,000 | -26,173,000 | 18,131,000 | 35,723,000 | — | -18,546,000 |
| Dec 2024 | 342,000 | -31,975,000 | -39,400,000 | 27,337,000 | 36,194,000 | — | -21,326,000 |
| Dec 2023 | 654,000 | -38,260,000 | -49,504,000 | 52,341,000 | 38,951,000 | — | -30,171,000 |
| Dec 2022 | 473,000 | -44,557,000 | -29,918,000 | 44,493,000 | 41,256,000 | — | -39,011,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.43
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $86.45M | $5.77 | — |
| CUE | Cue Biopharma, Inc. | $81.04M | $20.03 | — |
| MAIA | MAIA Biotechnology, Inc. | $80.87M | $1.33 | — |
| LFVN | Lifevantage Corp | $87.43M | $6.93 | — |
| ANVS | Annovis Bio, Inc. | $87.64M | $2.06 | — |
News headlines (Yahoo Finance, 1h cache)
3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced
2026-05-22 00:58 · Yahoo
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
2026-05-19 13:40 · Yahoo
3 Growth Stocks Insiders Are Betting On
2026-05-18 17:35 · Yahoo
Hennessy Capital Investment VII And 2 Insider-Favored Growth Stocks To Watch
2026-05-18 11:35 · Yahoo
Top Growth Companies With High Insider Ownership May 2026
2026-05-15 17:35 · Yahoo
3 High-Growth Insider-Owned Companies With Earnings Surging Up To 80%
2026-05-15 11:35 · Yahoo
3 Growth Companies With High Insider Ownership And Up To 71% Earnings Growth
2026-05-14 17:36 · Yahoo
Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates
2026-05-14 13:10 · Yahoo
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
2026-05-14 12:00 · Yahoo
3 Growth Companies With High Insider Ownership And 27% Revenue Growth
2026-05-14 11:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.